Capital Research Global Investors Pfizer Inc Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Pfizer Inc stock. As of the latest transaction made, Capital Research Global Investors holds 1,507,603 shares of PFE stock, worth $42.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,507,603

Previous 1,505,865 0.12%

Holding current value

$42.2 Million

Previous $43.4 Million 3.5%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $44,996 - $51,670	1,738 Added 0.12%	1,507,603 $41.8 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $4,781 - $6,211	-183 Reduced 0.01%	1,505,865 $43.4 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $107 Million - $125 Million	-3,342,706 Reduced 68.94%	1,506,048 $50 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $35,542 - $41,121	984 Added 0.02%	4,848,754 $178 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $27.2 Million - $35.4 Million	689,590 Added 16.58%	4,847,770 $198 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $28.4 Million - $37.1 Million	679,981 Added 19.55%	4,158,180 $213 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $25.2 Million - $30.8 Million	575,935 Added 19.84%	3,478,199 $152 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $65 Million - $77.1 Million	1,397,525 Added 92.87%	2,902,264 $152 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $2,745 - $3,401	60 Added 0.0%	1,504,739 $77.9 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $15,874 - $17,902	474 Added 0.03%	1,504,679 $54.5 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $44,749 - $56,902	1,337 Added 0.09%	1,504,205 $55.4 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $113 Million - $133 Million	-3,570,216 Reduced 70.38%	1,502,868 $55.2 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $108 Million - $130 Million	3,570,105 Added 237.54%	5,073,084 $166 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $540 - $772	20 Added 0.0%	1,502,979 $49.1 Million
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $51,585 - $58,543	1,567 Added 0.1%	1,502,959 $58.9 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $1,754 - $2,275	-54 Reduced -0.0%	1,501,392 $53.9 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $50,551 - $56,757	1,367 Added 0.09%	1,501,446 $65 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $21.9 Million - $24.1 Million	-585,232 Reduced 28.06%	1,500,079 $63.7 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $121 Million - $138 Million	-3,157,413 Reduced 60.22%	2,085,311 $91 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $20.2 Million - $24.5 Million	586,398 Added 12.59%	5,242,724 $231 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $104 Million - $111 Million	3,156,326 Added 210.42%	4,656,326 $169 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $46.5 Million - $51.2 Million	1,500,000	1,500,000 $53.6 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Pfizer Inc Transaction History